Why the study?
Do drug-eluting stents increase the risk of stent thrombosis compared to bare-metal stents?
Do drug-eluting stents increase the risk of stent thrombosis compared to bare-metal stents?
Stent thrombosis rates are similar between drug-eluting and bare-metal stents, highlighting the critical importance of antiplatelet therapy adherence to prevent very late thrombotic events.
No takes yet. Share an insight, caveat, or question.
Adherence to antiplatelet therapy remains essential after DES; this Level 5 review leaves open comparative thrombosis risk versus BMS under contemporary regimens.
Park et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: